WCN24-1766 EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH MEMBRANOUS NEPHROPATHY - Hiddo J.L. Heerspink; David C. Wheeler; Ricardo Correa-Rotter; Jamie P. Dwyer; Anna Maria Langkilde; Patrick B. Mark; Michal Nowicki; Peter Rossing; Robert D. Toto; Glenn M. Chertow; Niels Jongs (Kidney International Reports)